Pharma Marketing News Vol. 8, #7
Welcome to the August 2009 issue of Pharma Marketing News.
Pharma Marketing News Vol. 8, #7
Welcome to the August 2009 issue of Pharma Marketing News.
In Medical Publishing, Is Disclosure Enough?
"Full disclosure" (aka, "transparency") is a term used so often these days that it is becoming meaningless or at least so transparent as to...
Nissen Puts Stake Through ACCME’s Heart at Senate Hearing on Industry-Funded CME
At yesterday's United States Senate Special Committee on Aging hearing on "Medical Research and Education: Higher Learning or Higher Earning?", most of the testimony...
Novo to Social Media: Report the Facts
A Twitter friend was surprised I did not respond "2 the Charlie Kimball thing- esp since your journalistic integrity was questioned. :("I had no...
On Twitter, A Patient Photo is Worth a Thousand Characters!
Pharma brand marketers have a problem with Twitter. They can only use 140 characters (about 20 words) at a time. That limitation, however, has...
The Social Media Revolution Will Not Be “Televised”
I spent the day yesterday attending ExL Pharma's 5th Annual Public Relations & Communications Summit, which was held at Pfizer headquarters in New York...
Pfizer’s Social Media Strategy: Piss Off John Mack, Get Hundreds of New Followers!
Ray Kerins (LinkedIn profile and @RayKerins?) -- Head, Global Media Relations at Pfizer -- and I were among the few people attending yesterday's "Social...
Pharma Shifts Support of CME from MECCs to Physician Societies
The 2009 annual report the Accreditation Council for Continuing Medical Education (ACCME's) is out and there are a few interesting takeaways:Overall Continuing Medical Education...
FDA Cannot Track Its Own Review of Adverse Event Reports!
I don't know whether to laugh or cry regarding a Government Accounting Office (GAO) report that said while the number of adverse-event reports -...
